Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$45.46
-7.7%
$70.18
$32.21
▼
$170.87
$1.53B21.14 million shs912,293 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.68%-13.19%-34.06%-47.79%-65.98%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$45.46
-7.7%
$70.18
$32.21
▼
$170.87
$1.53B21.14 million shs912,293 shs
10 Best Stocks to Own in Fall 2026 Cover

AI spending is reshaping the market, and the opportunity extends far beyond the biggest chipmakers. Discover 10 stocks set to benefit from powerful trends in AI infrastructure, cloud computing, energy, capital returns, and consumer growth this fall.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-7.68%-13.19%-34.06%-47.79%-65.98%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
GeneDx Holdings Corp. stock logo
WGS
GeneDx
2.89
Moderate Buy$90.1498.29% Upside

Current Analyst Ratings Breakdown

Latest WGS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
11/18/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$85.00
11/16/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
UpgradeHold ➝ Strong-Buy
11/10/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingBuy$90.00 ➝ $85.00
11/2/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Reiterated RatingSell (D)
10/9/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
DowngradeStrong-Buy ➝ Hold
10/1/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
Boost Price TargetBuy$74.00 ➝ $83.00
8/26/2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
UpgradeHold ➝ Strong-Buy
(Data available from 11/21/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$427.54M3.19$2.04 per share22.26$8.16 per share5.57
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
GeneDx Holdings Corp. stock logo
WGS
GeneDx
-$21.02M-$3.78N/A36.08N/A-24.10%1.98%1.02%N/A

Latest WGS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
11/9/2026Q3 2026
GeneDx Holdings Corp. stock logo
WGS
GeneDx
$0.0729$0.28+$0.2071-$0.41$122.93 million$123.10 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
GeneDx Holdings Corp. stock logo
WGS
GeneDx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
GeneDx Holdings Corp. stock logo
WGS
GeneDx
0.60
4.16
3.85

Institutional Ownership

CompanyInstitutional Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
61.72%

Insider Ownership

CompanyInsider Ownership
GeneDx Holdings Corp. stock logo
WGS
GeneDx
25.17%
CompanyEmployeesShares OutstandingFree FloatOptionable
GeneDx Holdings Corp. stock logo
WGS
GeneDx
1,30029.97 million22.43 millionOptionable

Recent News About These Companies

GeneDx (NASDAQ:WGS) Stock Rating Reaffirmed as Buy by BTIG Research
GeneDx Announces Leadership Transition - November 18, 2026
GeneDx Holdings Corp. Announces Management Changes
GeneDx (NASDAQ:WGS) Shares Climb 8.8% - What's Next?
GeneDx (NASDAQ:WGS) Earns "Buy" Rating from BTIG Research
GeneDx Announces Leadership Transition
GeneDx (NASDAQ:WGS) Stock Rating Upgraded by Zacks Research
GeneDx Earnings Call Highlights Growth and Profitability
GeneDx to Participate in Upcoming Investor Conferences
GeneDx Sees Unusually High Options Volume (NASDAQ:WGS)
Why GeneDx Holdings Stock Just Dropped 16.6%
4 Post-Earnings Losers Drawing Unusual Options Volume
GeneDx (NASDAQ:WGS) Shares Gap Down - Here's Why
GeneDx (WGS) Q3 2026 Earnings Call Transcript

New MarketBeat Followers Over Time

Media Sentiment Over Time

GeneDx stock logo

GeneDx NASDAQ:WGS

$45.46 -3.78 (-7.68%)
Closing price 11/20/2026 04:00 PM Eastern
Extended Trading
$45.42 -0.04 (-0.09%)
As of 11/20/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.